76 related articles for article (PubMed ID: 15363550)
1. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
Samara GJ; Lawrence DM; Chiarelli CJ; Valentino MD; Lyubsky S; Zucker S; Vaday GG
Cancer Lett; 2004 Oct; 214(2):231-41. PubMed ID: 15363550
[TBL] [Abstract][Full Text] [Related]
2. Interactions between CXCR4 and CXCL12 promote cell migration and invasion of canine hemangiosarcoma.
Im KS; Graef AJ; Breen M; Lindblad-Toh K; Modiano JF; Kim JH
Vet Comp Oncol; 2017 Jun; 15(2):315-327. PubMed ID: 26337509
[TBL] [Abstract][Full Text] [Related]
3. CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma.
Rioja-Blanco E; Arroyo-Solera I; Álamo P; Casanova I; Gallardo A; Unzueta U; Serna N; Sánchez-García L; Quer M; Villaverde A; Vázquez E; León X; Alba-Castellón L; Mangues R
J Exp Clin Cancer Res; 2022 Feb; 41(1):49. PubMed ID: 35120582
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells.
Ottaiano A; di Palma A; Napolitano M; Pisano C; Pignata S; Tatangelo F; Botti G; Acquaviva AM; Castello G; Ascierto PA; Iaffaioli RV; Scala S
Cancer Immunol Immunother; 2005 Aug; 54(8):781-91. PubMed ID: 15592929
[TBL] [Abstract][Full Text] [Related]
5. SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.
De-Colle C; Mönnich D; Welz S; Boeke S; Sipos B; Fend F; Mauz PS; Tinhofer I; Budach V; Jawad JA; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Bayer C; Belka C; Pigorsch S; Combs SE; Lohaus F; Linge A; Krause M; Baumann M; Zips D; Menegakis A
Clin Transl Radiat Oncol; 2017 Aug; 5():28-36. PubMed ID: 29594214
[TBL] [Abstract][Full Text] [Related]
6. CCR7 and CXCR4 Expression in Primary Head and Neck Squamous Cell Carcinomas and Nodal Metastases – a Clinical and Immunohistochemical Study.
Al-Jokhadar M; Al-Mandily A; Zaid Kh; Azar Maalouf E
Asian Pac J Cancer Prev; 2017 Apr; 18(4):1093-1104. PubMed ID: 28547946
[TBL] [Abstract][Full Text] [Related]
7. CXCL12-3' A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy?
Coelho A; Calçada C; Catarino R; Pinto D; Fonseca G; Medeiros R
Cancer Immunol Immunother; 2006 Jun; 55(6):639-43. PubMed ID: 16155757
[No Abstract] [Full Text] [Related]
8. CXCR4: A New Player in an Old Scene?
Knopf A; Fritsche MK; Li Y
ORL J Otorhinolaryngol Relat Spec; 2017; 79(1-2):34-42. PubMed ID: 28231592
[TBL] [Abstract][Full Text] [Related]
9. The effect of CXCL12 on survival outcomes of patients with viral hepatitis-associated hepatocellular carcinoma after hepatectomy.
Lu Y; Xing F; Peng S
Heliyon; 2024 May; 10(9):e30782. PubMed ID: 38756575
[TBL] [Abstract][Full Text] [Related]
10. The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma.
Lekan AA; Weiner LM
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339310
[TBL] [Abstract][Full Text] [Related]
11. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.
Bao S; Darvishi M; H Amin A; Al-Haideri MT; Patra I; Kashikova K; Ahmad I; Alsaikhan F; Al-Qaim ZH; Al-Gazally ME; Kiasari BA; Tavakoli-Far B; Sidikov AA; Mustafa YF; Akhavan-Sigari R
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7945-7968. PubMed ID: 36905421
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target.
Malik S; Westcott JM; Brekken RA; Burrows FJ
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008248
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck Cancers.
Singh S; Kumaravel S; Dhole S; Roy S; Pavan V; Chakraborty S
Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):93-102. PubMed ID: 33994734
[TBL] [Abstract][Full Text] [Related]
14. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
[TBL] [Abstract][Full Text] [Related]
15. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.
Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK
Front Immunol; 2020; 11():598532. PubMed ID: 33414786
[TBL] [Abstract][Full Text] [Related]
16. SDF-1/CXCR4 induces cell invasion through CD147 in squamous cell carcinoma of the hypopharynx.
Toyoma S; Suzuki S; Kawasaki Y; Yamada T
Oncol Lett; 2020 Aug; 20(2):1817-1823. PubMed ID: 32724425
[TBL] [Abstract][Full Text] [Related]
17. The Trinity of Matrix Metalloproteinases, Inflammation, and Cancer: A Literature Review of Recent Updates.
Ozkan E; Bakar-Ates F
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(3):206-221. PubMed ID: 32178620
[TBL] [Abstract][Full Text] [Related]
18. RNA interfering of CXCR4 inhibits the adhesion, invasion, and tumorigenicity of acute monocytic leukemic cells
Zheng J; Fu L; Li Z; Shi Q; Li J; Chen S
Int J Clin Exp Pathol; 2018; 11(1):68-75. PubMed ID: 31938088
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 and PD-1 Expression in Head and Neck Cancer with Perineural Spread.
Barnett CM; Sommerville RS; Lin C; Ratnayake G; Hughes B; Taheri T
J Neurol Surg B Skull Base; 2019 Feb; 80(1):18-22. PubMed ID: 30733896
[No Abstract] [Full Text] [Related]
20. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
